ArticleJournal of gastroenterology2026

Prior vedolizumab exposure and fibroblast-derived MMP13 are associated with ustekinumab nonresponse in ulcerative colitis.

Yuiko Tsuruta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.